BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 8270443)

  • 1. Evaluation of external-beam radiation therapy plus 5-fluorouracil (5-FU) versus external-beam radiation therapy plus hycanthone (HYC) in confined, unresectable pancreatic cancer.
    Earle JD; Foley JF; Wieand HS; Kvols LK; McKenna PJ; Krook JE; Tschetter LK; Schutt AJ; Twito DI
    Int J Radiat Oncol Biol Phys; 1994 Jan; 28(1):207-11. PubMed ID: 8270443
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concomitant intraarterial cisplatin, intravenous 5-flourouracil, and split-course radiation therapy for locally advanced unresectable pancreatic adenocarcinoma: a phase II study of the Puget Sound Oncology Consortium (PSOC-703).
    Thomas CR; Weiden PL; Traverso LW; Thompson T
    Am J Clin Oncol; 1997 Apr; 20(2):161-5. PubMed ID: 9124192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protracted venous infusion 5-fluorouracil with concomitant radiotherapy compared with bolus 5-fluorouracil for unresectable pancreatic cancer.
    Mehta VK; Poen JC; Ford JM; Oberhelman HA; Vierra MA; Bastidas AJ; Fisher GA
    Am J Clin Oncol; 2001 Apr; 24(2):155-9. PubMed ID: 11319291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels.
    Abrams RA; Grochow LB; Chakravarthy A; Sohn TA; Zahurak ML; Haulk TL; Ord S; Hruban RH; Lillemoe KD; Pitt HA; Cameron JL; Yeo CJ
    Int J Radiat Oncol Biol Phys; 1999 Jul; 44(5):1039-46. PubMed ID: 10421536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pilot study of chronomodulated infusional 5-fluorouracil chemoradiation for pancreatic cancer.
    Penberthy DR; Rich TA; Shelton CH; Adams R; Minasi JS; Jones RS
    Ann Oncol; 2001 May; 12(5):681-4. PubMed ID: 11432628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemoradiotherapy in the treatment of regional pancreatic carcinoma: a phase II study.
    Al-Sukhun S; Zalupski MM; Ben-Josef E; Vaitkevicius VK; Philip PA; Soulen R; Weaver D; Adsay V; Heilbrun LK; Levin K; Forman JD; Shields AF
    Am J Clin Oncol; 2003 Dec; 26(6):543-9. PubMed ID: 14663369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with chronomodulated infusional 5-fluorouracil chemoradiotherapy for pancreatic adenocarcinoma.
    Keene KS; Rich TA; Penberthy DR; Shepard RC; Adams R; Jones RS
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):97-103. PubMed ID: 15850908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase I study of hyperfractionated radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic cancer.
    Ueno H; Okusaka T; Ikeda M; Tokuuye K
    Oncology; 2004; 67(3-4):215-21. PubMed ID: 15557781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial of low dose N-phosphonacetyl-L-aspartic acid and high dose 5-fluorouracil administered concomitantly with radiation therapy for unresectable localized adenocarcinoma of the pancreas.
    Ardalan B; Ucar A; Reddy R; Livingstone AS; Markoe A; Schwade J; Richman SP; Donofrio K
    Cancer; 1994 Oct; 74(7):1869-73. PubMed ID: 8082092
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multi-institutional comparative trial of radiation therapy alone and in combination with 5-fluorouracil for locally unresectable pancreatic carcinoma. The Gastrointestinal Tumor Study Group.
    Ann Surg; 1979 Feb; 189(2):205-8. PubMed ID: 426553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intraoperative and conformal external-beam radiation therapy with protracted 5-fluorouracil infusion in patients with locally advanced pancreatic carcinoma.
    Furuse J; Kinoshita T; Kawashima M; Ishii H; Nagase M; Konishi M; Nakagohri T; Inoue K; Ogino T; Ikeda H; Maru Y; Yoshino M
    Cancer; 2003 Mar; 97(5):1346-52. PubMed ID: 12599244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose local irradiation plus prophylactic hepatic irradiation and chemotherapy for inoperable adenocarcinoma of the pancreas. A preliminary report of a multi-institutional trial (Radiation Therapy Oncology Group Protocol 8801).
    Komaki R; Wadler S; Peters T; Byhardt RW; Order S; Gallagher MJ; Herskovic A; Pederson J
    Cancer; 1992 Jun; 69(11):2807-12. PubMed ID: 1571912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 125I interstitial implant, precision high-dose external beam therapy, and 5-FU for unresectable adenocarcinoma of pancreas and extrahepatic biliary tree.
    Dobelbower RR; Merrick HW; Ahuja RK; Skeel RT
    Cancer; 1986 Nov; 58(10):2185-95. PubMed ID: 3756765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The feasibility of dose escalation using concurrent radiation and 5-fluorouracil therapy following pancreaticoduodenectomy for pancreatic carcinoma.
    Regine WF; John WJ; McGrath P; Strodel WE; Mohiuddin M
    J Hepatobiliary Pancreat Surg; 2000; 7(1):53-7. PubMed ID: 10982592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of locally unresectable cancer of the stomach and pancreas: a randomized comparison of 5-fluorouracil alone with radiation plus concurrent and maintenance 5-fluorouracil--an Eastern Cooperative Oncology Group study.
    Klaassen DJ; MacIntyre JM; Catton GE; Engstrom PF; Moertel CG
    J Clin Oncol; 1985 Mar; 3(3):373-8. PubMed ID: 3973648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid-fractionation preoperative chemoradiation, pancreaticoduodenectomy, and intraoperative radiation therapy for resectable pancreatic adenocarcinoma.
    Pisters PW; Abbruzzese JL; Janjan NA; Cleary KR; Charnsangavej C; Goswitz MS; Rich TA; Raijman I; Wolff RA; Lenzi R; Lee JE; Evans DB
    J Clin Oncol; 1998 Dec; 16(12):3843-50. PubMed ID: 9850029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pancreaticoduodenectomy for pancreatic adenocarcinoma: postoperative adjuvant chemoradiation improves survival. A prospective, single-institution experience.
    Yeo CJ; Abrams RA; Grochow LB; Sohn TA; Ord SE; Hruban RH; Zahurak ML; Dooley WC; Coleman J; Sauter PK; Pitt HA; Lillemoe KD; Cameron JL
    Ann Surg; 1997 May; 225(5):621-33; discussion 633-6. PubMed ID: 9193189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A phase I/II study of external beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 92-07): preliminary toxicity report.
    Gaspar LE; Qian C; Kocha WI; Coia LR; Herskovic A; Graham M
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):593-9. PubMed ID: 9112458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined intraoperative radiation and perioperative chemotherapy for unresectable cancers of the pancreas.
    Mohiuddin M; Regine WF; Stevens J; Rosato F; Barbot D; Biermann W; Cantor R
    J Clin Oncol; 1995 Nov; 13(11):2764-8. PubMed ID: 7595736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma.
    Ishii H; Okada S; Tokuuye K; Nose H; Okusaka T; Yoshimori M; Nagahama H; Sumi M; Kagami Y; Ikeda H
    Cancer; 1997 Apr; 79(8):1516-20. PubMed ID: 9118032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.